ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,08165
-0,69%
Bitcoin
69.323,05
-2,04%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Shattuck Labs Inc (STTK)

  7. Shattuck Labs Inc (STTK) News

STTK

Shattuck Labs (STTK)

Shattuck Labs Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:STTK
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202413h30GlobeNewswire Inc.Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk MyeNASDAQ:STTKShattuck Labs Inc
14/05/202422h15GlobeNewswire Inc.Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the EuNASDAQ:STTKShattuck Labs Inc
14/05/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
02/05/202413h05GlobeNewswire Inc.Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
09/04/202422h05GlobeNewswire Inc.Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:STTKShattuck Labs Inc
01/04/202413h00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STTKShattuck Labs Inc
08/03/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
08/03/202423h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
08/03/202423h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
06/03/202422h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
04/03/202413h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
04/03/202413h00GlobeNewswire Inc.Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of DirectorsNASDAQ:STTKShattuck Labs Inc
29/02/202422h41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STTKShattuck Labs Inc
29/02/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:STTKShattuck Labs Inc
29/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
29/02/202422h05GlobeNewswire Inc.Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
26/02/202413h00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming March ConferencesNASDAQ:STTKShattuck Labs Inc
14/02/202411h06PR Newswire (US)Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion ProteinsNASDAQ:STTKShattuck Labs Inc
13/02/202412h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
13/02/202412h00GlobeNewswire Inc.Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory DiseasesNASDAQ:STTKShattuck Labs Inc
02/02/202422h32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STTKShattuck Labs Inc
01/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:STTKShattuck Labs Inc
31/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
31/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
31/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
24/01/202422h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STTKShattuck Labs Inc
16/01/202422h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
16/01/202422h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
16/01/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
16/01/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
 Showing the most relevant articles for your search:NASDAQ:STTK

Kürzlich von Ihnen besucht

DBI
DAX
DAX
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
FX
EURGBP
Euro vs Sterling
TG
MBG
MercedesBenz
COIN
ETHUSD
Ethereum
USOTC
ADDYY
Adidas (QX)
TG
CBK
Commerzbank
DBI
MDAX
MDAX
NASDAQ
GOOGL
Alphabet
TG
D7G
Nel ASA
FX
EURUSD
Euro vs US Dollar
NYSE
JPM
JP Morgan Chase
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten